View Older Stories View More Recent Stories

Dec 16, 2021 08:03AM Tasso Secures $100M in Series B Financing
Dec 16, 2021 07:00AM Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding to Advance Manufacturing and Expand Commercialization of NX One Platform
Dec 15, 2021 09:00AM Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucoma
Dec 7, 2021 08:00AM PepGen Appoints Vice President of Program Management and Promotes Sonia Bracegirdle, Ph.D., to Senior Vice President, Strategy & Operations
Dec 7, 2021 08:00AM Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection
Dec 7, 2021 07:00AM Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Dec 7, 2021 02:00AM Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Dec 6, 2021 07:03AM NanoMosaic Closes a $40.75MM Over-Subscribed Series A Round
Dec 1, 2021 06:30AM Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals
Dec 1, 2021 03:00AM Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders
Nov 19, 2021 04:31PM Form SC 13G IO Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 16, 2021 08:00AM AavantiBio Further Enhances Leadership Team with Appointment of Jenny Marlowe, Ph.D. as Chief Scientific Officer
Nov 15, 2021 05:13PM Form SC 13G/A ARYA Sciences Acquisitio Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 05:07PM Form SC 13G/A Trillium Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 05:01PM Form SC 13G/A Aadi Bioscience, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 05:01PM Form SC 13G LianBio Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 04:57PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 15, 2021 04:50PM Form SC 13G/A Helix Acquisition Corp Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 04:49PM Form SC 13G/A CURIS INC Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 04:44PM Form SC 13G/A Inozyme Pharma, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 04:41PM Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 15, 2021 07:05AM Hydrus Microstent Lowers Visual Field Loss by 47% According to New 5-Year Pivotal Trial Data
Nov 12, 2021 04:33PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 11, 2021 08:00AM Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
Nov 11, 2021 08:00AM Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
Nov 9, 2021 07:00AM Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
Nov 8, 2021 08:00AM PepGen Bolsters R&D Team with Appointment of Jaya Goyal, Ph.D., as Executive Vice President of Research and Preclinical Development
Nov 8, 2021 05:39AM Alcon (ALC) to Acquire Ivantis for $475M Upfront
Nov 8, 2021 12:59AM Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
Nov 8, 2021 12:59AM Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
Nov 5, 2021 04:35PM Form SC 13G Xilio Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Nov 4, 2021 07:06AM Concert Pharma (CNCE) Announces $65M Institutional Financing
Nov 4, 2021 07:00AM Concert Pharmaceuticals Announces $65 Million Financing
Nov 3, 2021 07:30AM Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV
Oct 28, 2021 04:32PM Form SC 13D/A Forma Therapeutics Holdi Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 28, 2021 04:24PM Form SC 13D/A Kala Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 28, 2021 08:00AM PepGen Appoints Noel Donnelly as Chief Financial Officer
Oct 25, 2021 04:36PM Form SC 13G OTONOMY, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 25, 2021 04:34PM Form SC 13G Pyxis Oncology, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 25, 2021 06:30AM Cedilla Therapeutics Completes $82.6M Series B Financing
Oct 13, 2021 08:00AM PepGen Welcomes Esteemed Neurologist Dr. John Day to Scientific Advisory Board
Oct 12, 2021 07:00AM AavantiBio Furthers Strategic Partnership with University of Florida to Research and Develop Next Generation Gene Therapy Capsids
Oct 7, 2021 07:30AM DTx Pharma to Participate in the 8th Annual Fall Private Company Showcase with Solebury Trout and BMO
Oct 6, 2021 08:40AM RA Capital Management, LP Closes $880 Million Venture Capital Fund
Oct 5, 2021 07:30AM DTx Pharma to Present at the OIS Retina Innovation Showcase
Oct 4, 2021 07:30AM Delix Therapeutics Named One of Fierce Biotech’s “Fierce 15” Companies of 2021
Oct 4, 2021 07:30AM Delix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021
Oct 1, 2021 04:31PM Form SC 13G SYNLOGIC, INC. Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 29, 2021 07:00AM Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
Sep 28, 2021 08:15AM Nucleate launches nationwide to empower the next generation of biotech leaders
View More Recent Stories View Older Stories